Successful treatment of pemphigus vulgaris with obinutuzumab
This letter highlights the successful use of obinutuzumab as an alternative therapy for a patient with pemphigus vulgaris who could not tolerate rituximab. Our findings suggest that obinutuzumab may offer a promising treatment option for patients with autoimmune skin diseases when first-line therapies fail.
Authors
- Brittney Schultz (ORCID: https://orcid.org/0000-0001-5080-892X)
- Colin Tang-Whitmore (ORCID: https://orcid.org/0009-0006-9307-5168)
- Laureb Ostlund
- Kati Munson
Institutions
- Fairview Health Services (US)
- University of Minnesota Medical Center (US)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/bjd/ljaf201
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00